Axona

Thumped by the FDA, Accera’s attempt to do a serious Alzheimer’s PhIII ends with a flop
Endpoints
Tue, 02/28/17 - 11:14 am
FDA
Accera
Alzheimer's disease
clinical trials
Axona
medical food